Bioventus Inc.
$10.28
▼
-1.97%
2026-04-21 05:50:00
www.bioventus.com
NMS: BVS
Explore Bioventus Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$874.79 M
Current Price
$10.28
52W High / Low
$10.76 / $5.81
Stock P/E
38.48
Book Value
$2.74
Dividend Yield
—
ROCE
10.76%
ROE
13.17%
Face Value
—
EPS
$0.33
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
930
Beta
0.69
Debt / Equity
136.29
Current Ratio
1.7
Quick Ratio
1.19
Forward P/E
10.35
Price / Sales
1.07
Enterprise Value
$914.8 M
EV / EBITDA
11.78
EV / Revenue
1.61
Rating
Strong Buy
Target Price
$14.8
EPS Forecast (FY)
—
Pros
- Short-term liquidity looks comfortable.
Cons
- Leverage is relatively high.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | 20/20 Biolabs, Inc. | $1.71 | — | — | — | -253.94% | -5.03% | $50 / $1.51 | $0.01 |
| 2. | Electromed, Inc. | $25.4 | 23.98 | $215.65 M | — | 22.29% | 20.2% | $30.73 / $17.73 | $5.49 |
| 3. | Envoy Medical, Inc. | $0.7 | — | $54.48 M | 3.34% | 741.34% | 155.22% | $1.91 / $0.36 | $-0.41 |
| 4. | Treace Medical Concepts, Inc. | $1.97 | — | $125.31 M | — | -33.86% | -58.94% | $7.78 / $1.17 | $1.37 |
| 5. | iTonic Holdings Ltd. | $0.32 | — | $5.41 M | — | -59.82% | -71.25% | $32 / $0.25 | $0.36 |
| 6. | InMode Ltd. | $14.57 | 9.84 | $923.14 M | — | 12.27% | 13.53% | $16.74 / $12.72 | $10.78 |
| 7. | Pulsenmore Ltd. | $3.33 | — | $72.38 M | — | -33.09% | -17.62% | $1,468 / $1,000 | — |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 157.9 M | 138.65 M | 147.66 M | 123.88 M | 153.64 M | — |
| Operating Profit | 21.72 M | 11.25 M | 18.37 M | 4.95 M | 11.03 M | — |
| Net Profit | 14.76 M | 3.15 M | 7.46 M | -2.64 M | -0.16 M | — |
| EPS in Rs | 0.22 | 0.05 | 0.11 | -0.04 | -0 | — |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 568.09 M | 573.28 M | 512.35 M | 512.12 M |
| Operating Profit | 56.29 M | 22.82 M | 2.03 M | -34.66 M |
| Net Profit | 22.73 M | -36.12 M | -156.23 M | -158.7 M |
| EPS in Rs | 0.34 | -0.54 | -2.32 | -2.36 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 683.56 M | 727.96 M | 810.91 M | 1.37 B |
| Total Liabilities | 455.11 M | 542.35 M | 589.79 M | 960.43 M |
| Equity | 184.1 M | 147.94 M | 173.59 M | 325.24 M |
| Current Assets | 272.84 M | 275.61 M | 268 M | 272.57 M |
| Current Liabilities | 160.38 M | 210.4 M | 175.5 M | 304.02 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 74.67 M | 38.8 M | 15.34 M | -13.54 M |
| Investing CF | -3.25 M | 22.96 M | 15.81 M | -116.44 M |
| Financing CF | -62.14 M | -54.58 M | -26.65 M | 62.08 M |
| Free CF | 72.11 M | 37.79 M | 7.98 M | -15.02 M |
| Capex | -2.56 M | -1.01 M | -7.36 M | -1.48 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 11.89% | 0.04% | — | — |
| Earnings Growth % | 76.88% | 1.56% | — | — |
| Profit Margin % | -6.3% | -30.49% | -30.99% | — |
| Operating Margin % | 3.98% | 0.4% | -6.77% | — |
| Gross Margin % | 67.72% | 64.06% | 64.65% | — |
| EBITDA Margin % | 6.28% | -4.5% | -23.75% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.